ICON Public Limited Company (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against the other AI stocks.

As the global AI race heats up with rapid developments in Asia, led by China, the UK government is attempting to strengthen its relationship with the US, with AI at the forefront of the transatlantic collaboration. The UK Prime Minister confirmed during a visit to the White House in February that the nations are working on a new economic plan focusing on advanced technologies.

Meanwhile, US Vice President J.D. Vance said on March 18th that freeing AI from regulation is beneficial for American workers and tech innovators.

“I think there’s too much fear that AI will simply replace jobs rather than augmenting so many of the things that we do now,” said Vance at the Andreessen Horowitz American Dynamism Summit in Washington, D.C.

Although he acknowledged that AI could lead to the displacement of jobs, the vice president highlighted that historical evidence shows that innovation helps create higher-paying jobs.

Elsewhere, OpenAI described DeepSeek as state-controlled in a new policy proposal. It urged the US government to consider banning models from the outfit, claiming potential security risks due to its possible connection with the People’s Republic of China (PRC). OpenAI had previously accused DeepSeek of “distilling” knowledge from OpenAI’s models in violation of its terms of service.

“We’re not advocating for restrictions on people using models like DeepSeek. What we’re proposing are changes to U.S. export rules that would allow additional countries to access U.S. compute on the condition that their datacenters don’t rely on PRC technology that present[s] security risks — instead of restricting their access to chips based on the assumption that they will divert technology to the PRC. The goal is more compute and more AI for more countries and more people.”

-said OpenAI spokesperson Liz Bourgeois.

We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s Q4 2024 database of over 1000 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations

A laboratory setting with a team of scientists working on a clinical trial.

ICON Public Limited Company (NASDAQ:ICLR)

Number of Hedge Fund Followers: 46

ICON Public Limited Company (NASDAQ:ICLR) is a leading healthcare intelligence and clinical research organization innovating next-gen therapies for better patient outcomes. The company outsources its diverse services to pharma, biotech, medical device, and public health organizations.

On March 20th, ICON Public Limited Company (NASDAQ:ICLR) announced it would begin utilizing clinical trial solutions provider Medidata’s AI-based Clinical Data Studio to advance its studies, optimize clinical workflows, accelerate decision-making, improve operational oversight, and facilitate AI-driven risk assessment strategies for sponsors.

“ICON leads in risk-based quality management, integrating Data Management and Central Monitoring teams in our Clinical Data Science group. To meet growing data demands and customer expectations for speed and efficiency, we selected Clinical Data Studio. This platform streamlines data review, central monitoring, and medical review processes using AI and statistical modeling for faster, precise data delivery.”

-said Evan Hughes, vice president of clinical data science at Icon Plc.

Overall, ICLR ranks 5th on our list of trending AI stock updates on Wall Street today. While we acknowledge the potential of ICLR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ICLR but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.